Lipopolysaccharide inhibits osteoblast formation and receptor activator of nuclear factor-κB ligand degradation via autophagy inhibition
Lipopolysaccharide (LPS) and Receptor Activator of Nuclear Factor-κB Ligand (RANKL) are the two important factors causing bone loss, which is an important pathogenesis for osteoporosis. However, the relationship between LPS and RANKL is not yet clear. LPS can be involved in the weakened osteoblast f...
Saved in:
Main Authors: | Huaizhi Zhang, Jianhua Lin, Xu Chen, Jianhui Dai, Haibin Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2024-04-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/71/4/71_EJ23-0484/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-17 prevents oxidative stress from damaging osteoblast formation by inhibiting autophagic degradation of metallothionein-2
by: Xueyan Ling, et al.
Published: (2024-06-01) -
Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment
by: Qifan Yang, et al.
Published: (2025-01-01) -
Bioactive Compounds from Propolis on Bone Homeostasis: A Narrative Review
by: Vanessa Bertolucci, et al.
Published: (2025-01-01) -
Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy
by: Changfang Luo, et al.
Published: (2025-01-01) -
BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
by: He Qian, et al.
Published: (2024-12-01)